During the past decade, LTD Health House conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "LTD Health House" are "Advanced Breast Cancer" (1 trials), "Breast Cancer" (1 trials), "Dedifferentiated Liposarcoma" (1 trials) and "Early Breast Cancer" (1 trials). Many other conditions were trialed in "LTD Health House" in a lesser frequency.

Most popular intervention types in "LTD Health House" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "EG12014" (1 trials), "Endocrine Therapy of Physician's Choice" (1 trials), "Giredestrant" (1 trials), "Herceptin" (1 trials) and "LHRH Agonist" (1 trials). Other intervention names were less common.

The vast majority of trials in "LTD Health House" are 3 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "LTD Health House". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in LTD Health House, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in LTD Health House, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".